For patients interested in combination therapy, switching from semaglutide to PlexusDx's Tirzepatide Injection or GLP-Squared Injection (which combines semaglutide and tirzepatide) typically occurs after the semaglutide dose levels drop sufficiently to avoid dual-overlap side effects
App Store listings on July 23, 2026
Weight loss is one phase
Those showing minimal early response may need dose adjustments, medication switching, or acknowledgment that their particular physiology responds less robustly to these receptor agonist approaches
Insulin Glargine) SURPASS-4 was a cardiovascular outcomes trial designed to assess the safety of Tirzepatide in a high-risk population of 1,995 adults with T2D and established cardiovascular (CV) disease or high risk factors for CV disease
doi: 10.1210/jc.2017-02449 10 Mauvais-Jarvis F, Manson JE, Stevenson JC, Fonseca VA